Consensus molecular subtypes as biomarkers of FU/FA maintenance therapy with or without panitumumab in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212).

ABSTRACT: Customized Nanostring PanCancer Progression Panel performed on FFPE tumor tissue derived from treatment naive metastatic colorectal cancer patients included into the randomized phase 2 PanaMa trial.

ORGANISM(S): Homo sapiens

PROVIDER: GSE221953 | GEO | 2023/02/15

REPOSITORIES: GEO